National Institutes of Health United States

Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)

Open Health Posted 8 Jun 2026

Award range Up to $1,000,000

Deadline 9 Oct 2026, 00:00 9 days left

Total funding $3,000,000

Expected awards 3

Overview

Funding agency: National Institutes of Health HHS-NIH11
Reference: RFA-DK-27-121
Funding programme: Health
Funding instrument: Cooperative agreement
Cost sharing: Not required
Region: United States
Source: Grants.gov (US Federal)

Description

This Notice of Funding Opportunity (NOFO) invites applications from clinical centers to participate in a consortium to test anti-obesity medication (AOM) treatment strategies for youth with obesity that maximize benefits and minimize risks of AOM use. Such intervention strategies should support the promotion of healthy growth and development; adequate nutritional status/intake, healthy eating…

Sign up to view full grant details

Create a free account to unlock the complete grant description, funding details, eligibility criteria, and application links.

Full description Funding amounts & eligibility Application links & deadlines Save & track grants

Overview

Description

Sign up to view full grant details

Related grants

Send to CRM

CRM Integration Required

Email Grant